Christophe L.
- Country
- Belgium
- Department
- Oncology
Research Overview
- A Phase 3, Randomized, Open-label, Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination versus Intravenous Nivolumab + Relatlimab Fixed-dose Combination in Participants with Previously Untreated Metastatic or Unresectable Melanoma
- Efficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- A Phase 3, Randomized, Double-Blind Study of Adjuvant Immunotherapy with Nivolumab versus Placebo after Complete Resection of Stage IIB/C Melanoma (CheckMate 76K: CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 76K)
Data & Insights
Has run more than one trial at 37 of 164 partner sites.
Specializations
Melanoma Research
The investigator specializes in treating advanced melanoma, with particular focus on both metastatic and unresectable cases. Their research extends to innovative approaches in melanoma prevention and recurrence management, particularly in patients with completely resected Stage IIB/C disease.
- Advanced Stage Melanoma Treatment
- Post-surgical Recurrence Prevention
- Subcutaneous Treatment Administration
Their work encompasses both systemic treatments and preventive therapeutic strategies for melanoma patients.
Head and Neck Cancer
The investigator conducts research in head and neck squamous cell carcinoma, focusing specifically on treating recurrent and metastatic disease. Their work involves evaluating novel combination therapy approaches.
- Advanced HNSCC Treatment
- Combination Therapy Strategies
- Metastatic Disease Management
Their research aims to advance treatment options for patients with challenging head and neck cancers.
Immunotherapy Applications
The investigator explores various immunotherapeutic approaches across multiple cancer types, including the development and evaluation of novel drug combinations and administration routes.
- Alternative Drug Delivery Methods
- Combination Immunotherapy
- Treatment Response Assessment
Their work includes investigating both established and experimental immunotherapy protocols.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.